We acknowledge several limitations to the present study: a) the absence of carriers of mutations in the TMEM127/SDHAF2/MAX/SDHA genes; and b) the absence of screening of tumors for somatic mutations, mainly in apparently sporadic tumors, that could potentially occur and influence the presented tumor metabolomic profiles. The gene discussed is SDHAF2; the disease is neoplasm.